February 1, 2026 · Form 4 insider transaction
DARGAN CHARLES K bought 300,000 shares of BIOLARGO, INC., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2026, through January 31, 2027.